Supplementary Table 1 from Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI

MLA

James L. Rubenstein, et al. Supplementary Table 1 from Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22443713.v1.

APA

James L. Rubenstein, Lloyd E. Damon, Soonmee Cha, Marc A. Shuman, Joan O’Brien, Patrick Treseler, Michael McDermott, James Hwang, Caroline M. Behler, Samar Issa, Francisco Valles, & Matthew J. Wieduwilt. (2023). Supplementary Table 1 from Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI. https://doi.org/10.1158/1078-0432.22443713.v1

Chicago

James L. Rubenstein, Lloyd E. Damon, Soonmee Cha, Marc A. Shuman, Joan O’Brien, Patrick Treseler, Michael McDermott, et al. 2023. “Supplementary Table 1 from Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI,” March. doi:10.1158/1078-0432.22443713.v1.